Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Myelodysplastic Syndromes 87Leukemia 83Leukemia, Myeloid, Acute 75Precursor Cell Lymphoblastic Leukemia-Lymphoma 62Lymphoma 58Leukemia, Lymphocytic, Chronic, B-Cell 57Lymphoma, Non-Hodgkin 53Multiple Myeloma 50Hodgkin Disease 47Myeloproliferative Disorders 45Leukemia, Myeloid, Chronic-Phase 41Lymphoma, Follicular 39Leukemia, Myeloid, Accelerated Phase 39Lymphoma, Mantle-Cell 38Lymphoma, Large B-Cell, Diffuse 38Lymphoma, B-Cell, Marginal Zone 38Burkitt Lymphoma 36Neoplasms, Plasma Cell 33Congenital Abnormalities 33Lymphoma, Large-Cell, Immunoblastic 31Primary Myelofibrosis 28Graft vs Host Disease 28Blast Crisis 28Leukemia, Myelomonocytic, Chronic 27Myelodysplastic-Myeloproliferative Diseases 24Dendritic Cell Sarcoma, Interdigitating 24Anemia, Refractory, with Excess of Blasts 24Recurrence 23Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23

Interventions

Cisplatin 7Etoposide 6Amifostine 6Radiotherapy 5Drug Therapy 5Cyclophosphamide 5apatinib 4Methotrexate 4Filgrastim 4Cytarabine 4sodium thiosulfate 3Methylprednisolone 3Carboplatin 3pegfilgrastim 2glucarpidase 2etoposide phosphate 2Voriconazole 2Vincristine 2Social Determinants of Health 2Pyridoxine 2Nivolumab 2Gemcitabine 2Doxorubicin 2Docetaxel 2Chemotherapy, Adjuvant 2Capecitabine 2trastuzumab deruxtecan 1selinexor 1sargramostim 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Drug-Related Side Effects and Adverse Reactions × Antilymphocyte Serum × Clear all
NCT00317798 2011-08-30

Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

University of Rochester

Phase 1 Completed
18 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡